Investing long-term in the cell & gene therapies of the future

Cell & Gene Therapy Insights 2023; 9(5), 299–303


Published: 29 March 2023
Geeta Vemuri

David McCall, Senior Editor, BioInsights, speaks to Geeta Vemuri, Founder and Managing Partner, Agent Capital, about her VC company's portfolio of advanced therapy investments, and the keys to obtaining funding in a difficult environment. (From an interview conducted on February 22nd, 2023).